Patients who had successful primary surgery for idiopathic MHs at the Hospital rechts der Isar, Technical University of Munich, Germany, and at The Royal Liverpool University Hospital, UK, between 2016 and 2019 were included. Approval was obtained from the ethics committee or the local institutional review board and complied with the Declaration of Helsinki and informed consent was obtained. Surgery consisted of a 25 or 23-gauge PPV, an ILM peel either with the conventional technique (complete removal of the ILM around the hole) or with an inverted ILM-flap (ILM outside the parafoveal area was peeled but an ILM flap anchored on the edge of the hole was inverted and positioned to cover the MH), and a tamponade with either 16% perfluoroethane (C2F6) or 12% perfluoropropane (C3F8) 12%. All patients had a pre-operative radial OCT scan, and a follow-up at 2 months and at 12 months by which stage they were all pseudophakic. Exclusion criteria were recurrent and secondary MH, high myopia (>8.00 diopter [D]), amblyopia, and any identified vision limiting co-pathology.
MHs were assessed using OCT (Heidelberg Spectralis, macular scan with TruTrack active eye tracking) with 24 to 48 radial lines through the center of the MH. All OCT images were converted from the 1:1 µm mode (
Fig. 1) into the 1:1 pixel mode (
Fig. 2) and uploaded in the graphic program ImageJ (version 2.0.0-rc-69/1.52p) and evaluated by two independent retinal specialists. Postoperative OCT images were taken at 2 months due to the presence of residual gas tamponade within the first few weeks after surgery.
Patient demographics collected included age, sex, duration of symptoms, lens status, pre- and postoperative best-corrected visual acuity (BCVA) logMAR, MH size as MLD and BD. The duration of the MH was based on the duration of symptoms. The main outcomes were the postoperative residual mean defect lengths in the ELM and EZ at 2 months and the BCVA at 12 months.